PMID- 20395677 OWN - NLM STAT- MEDLINE DCOM- 20101012 LR - 20220223 IS - 1421-9670 (Electronic) IS - 0250-8095 (Print) IS - 0250-8095 (Linking) VI - 31 IP - 5 DP - 2010 TI - Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. PG - 442-55 LID - 10.1159/000296717 [doi] AB - BACKGROUND/AIMS: In this study we tested the hypothesis that H(2)S regulates collagen deposition, matrix metalloproteinases (MMP) and inflammatory molecules during hyperhomocysteinemia (HHcy) resulting in attenuation of glomerulosclerosis and improved renal function. MATERIALS AND METHODS: A genetic model of HHcy, cystathionine beta-synthase heterozygous (CBS+/-) and wild-type (WT) 2-kidney (2K) mice were used in this study and supplemented with or without NaHS (30 micromol/l, H(2)S donor) in drinking water for 8 weeks. To expedite the renal damage associated with HHcy, uninephrectomized (1K) mice of similar groups were also used. RESULTS: Results demonstrated that NAD(P)H oxidase (p47(phox)subunit) and blood pressure were upregulated in WT 1K, CBS+/- 2K and CBS+/- 1K mice with downregulation of H(2)S production and reduced glomerular filtration rate. These changes were normalized with H(2)S supplementation. Both pro- and active MMP-2 and -9 and collagen protein expressions and glomerular depositions were also upregulated in WT 1K, CBS+/- 2K and CBS+/- 1K mice. Increased expressions of inflammatory molecules, intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1, as well as increased macrophage infiltration, were detected in WT 1K, CBS+/- 2K and CBS+/- 1K mice. These changes were ameliorated with H(2)S supplementation. CONCLUSION: Together, these results suggest that increased oxidative stress and decreased H(2)S in HHcy causes matrix remodeling and inflammation resulting in glomerulosclerosis and reduced renal function. CI - 2010 S. Karger AG, Basel. FAU - Sen, Utpal AU - Sen U AD - Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA. u0sen001 @ louisville.edu FAU - Munjal, Charu AU - Munjal C FAU - Qipshidze, Natia AU - Qipshidze N FAU - Abe, Oluwasegun AU - Abe O FAU - Gargoum, Riyad AU - Gargoum R FAU - Tyagi, Suresh C AU - Tyagi SC LA - eng GR - R01 HL074185/HL/NHLBI NIH HHS/United States GR - R01 HL071010/HL/NHLBI NIH HHS/United States GR - R01 NS051568/NS/NINDS NIH HHS/United States GR - R01 HL088012/HL/NHLBI NIH HHS/United States GR - NS-51568/NS/NINDS NIH HHS/United States GR - HL-74185/HL/NHLBI NIH HHS/United States GR - HL-88012/HL/NHLBI NIH HHS/United States GR - HL-71010/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20100416 PL - Switzerland TA - Am J Nephrol JT - American journal of nephrology JID - 8109361 RN - 0LVT1QZ0BA (Homocysteine) RN - 9007-34-5 (Collagen) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) RN - EC 4.2.1.22 (Cystathionine beta-Synthase) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - Animals MH - Collagen/chemistry MH - Cystathionine beta-Synthase/metabolism MH - Down-Regulation MH - Homocysteine/*metabolism MH - Hydrogen Sulfide/*metabolism MH - Hyperhomocysteinemia/metabolism MH - Inflammation MH - Kidney/pathology MH - Kidney Diseases/*etiology/*metabolism MH - Male MH - Matrix Metalloproteinase 2/metabolism MH - Matrix Metalloproteinase 9/metabolism MH - Mice MH - Mice, Inbred C57BL PMC - PMC2883848 EDAT- 2010/04/17 06:00 MHDA- 2010/10/13 06:00 PMCR- 2011/05/01 CRDT- 2010/04/17 06:00 PHST- 2010/01/11 00:00 [received] PHST- 2010/03/08 00:00 [accepted] PHST- 2010/04/17 06:00 [entrez] PHST- 2010/04/17 06:00 [pubmed] PHST- 2010/10/13 06:00 [medline] PHST- 2011/05/01 00:00 [pmc-release] AID - 000296717 [pii] AID - ajn0031-0442 [pii] AID - 10.1159/000296717 [doi] PST - ppublish SO - Am J Nephrol. 2010;31(5):442-55. doi: 10.1159/000296717. Epub 2010 Apr 16.